Release Date: February 28, 2019Expiration Date: February 29, 2020 Introduction This guideline was developed by a group of multiple sclerosis (MS) specialists, convened by the Consortium of Multiple Sclerosis Centers (CMSC), to serve as an educational guide and concise summary of available data and professional recommendations on the selection of disease-modifying therapy (DMT) for MS. …
Continue reading “CMSC Practical Guidelines for the Selection of Disease Modifying Therapies in MS”
Release Date: February 28, 2019Credit for this program expires February 29, 2020 Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, and other members of the healthcare team who manage patients with multiple sclerosis (MS). Learning Objectives Upon completion of this educational activity, the …
Release Date: February 1, 2019Valid for Credit Through: February 1, 2020 Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Identify different methods of managing fatigue in people with progressive MS and the …
Target Audience This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS). Program Description MS care providers need to continually update best practices and procedures to accommodate guideline changes, research developments, and new therapeutic strategies. Among the newer guidelines are the updated …
Continue reading “New Diagnostic and MRI Criteria for MS: How Will They Change our Practice?”
Management of MS in a pediatric patient— especially in a younger child—requires a careful approach that differs in many respects from that of adults with MS. There is a need to consider the impact of treatment on the developing immune system and brain and over a longer-term disease course. This special supplement addresses the challenges …
Continue reading “Pediatric Multiple Sclerosis: Sourcebook for MS Care Professionals”
Target Audience This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS). Program Description In MS management, the concepts of NEDA for “no evidence of disease activity” and MEDA for “minimal evidence of disease activity” have emerged in an attempt to define …
Continue reading “NEDA or MEDA? Defining Treatment Goals in Multiple Sclerosis”
Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Describe new approaches to optimize adherence through shared decision-making and patient engagement principles. 2) Integrate shared decision-making principles and models into clinical practice. Accreditation …
Continue reading “IJMSC: Impact of Shared Decision Making on Disease-Modifying Drug Adherence in MS”
Nurse practitioners in primary care settings are on the first line to recognize motor, sensory, and cognitive deficits that may help establish a diagnosis of MS. While referral to a neurologist is often made, patients with chronic illnesses such as MS often return to the primary care setting for management. In their multi-faceted roles of …
Continue reading “NP Connections: The Role of the Nurse Practitioner in Multiple Sclerosis Care”
For many patients with MS, current disease-modifying therapies (DMTs) can provide control of disease activity especially when more aggressive treatment is initiated early in the disease course. The CE-certified supplement, Risk-Benefit Analysis and Personalized Treatment in Multiple Sclerosis: Basing Treatment Goals on the Latest Evidence, provides clinicians with the most up-to-date evidence on current and …
Continue reading “Risk-Benefit Analysis and Personalized Treatment in MS”
Release Date: 6/30/2020 Expiration Date: 6/29/2021 The third edition of the Advances in Multiple Sclerosis Primer provides an educational experience featuring interactive cases and expert faculty commentary on a variety of MS topics. The content contains many recent updates to the second edition, as well as new sections including diagnosis and continuity of care. Click …
Continue reading “Advances in Multiple Sclerosis (AIMS) Primer: Third Edition”
CMSC Scholar © 2020 All rights Reserved | Proudly Created by Adapting Social
